G. Tuan

Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea.

E. Martinelli, R. Cricchio, P. Antonini, 1981, The Journal of antibiotics.

Metabolism of deflazacort in the rat, dog and man.

A. Assandri, E. Martinelli, P. Ferrari, 1979, Drug metabolism and disposition: the biological fate of chemicals.

Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dog.

G. Tarzia, A. Assandri, L. Zerilli, 1985, Xenobiotica; the fate of foreign compounds in biological systems.

Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drug.

G. Tarzia, A. Assandri, L. Zerilli, 1987, Xenobiotica; the fate of foreign compounds in biological systems.

Pyrrolyridine analogs of nalidixic acid. I: Pyrrolo[2,3-b]pyridines

G. Tarzia, P. Ferrari, G. Tuan, 1986 .

Identification of 5-hydroxypyrazinamide isolated from urine of subjects given pyrazinamide.

L. Zerilli, P. Ferrari, G. Tuan, 1987, Journal of chromatography.

Disposition and metabolism of a new steroidal anti-inflammatory agent, deflazacort, in cynomolgus monkeys.

A. Assandri, L. Zerilli, P. Ferrari, 1983, Xenobiotica; the fate of foreign compounds in biological systems.

Metabolic pathways of the contragestational agent, 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole (DL 111-IT), in the rat.

A. Assandri, L. Zerilli, P. Ferrari, 1984, Xenobiotica; the fate of foreign compounds in biological systems.

Influence of metabolism on the activity of a new anti-fertility agent, 2-(3-ethoxyphenyl)-5,6-dihydro-s-triazolo [5,1-a]isoquinoline (DL 204-IT), in the rat and the hamster.

A. Assandri, E. Martinelli, P. Ferrari, 1981, Arzneimittel-Forschung.